Presently, antimicrobial resistance has become a serious global threat, affecting millions of lives worldwide. It not only affects health but also adversely impacts therapeutic outcomes and clinical trials to develop new drugs—consequently resulting in treatment failure. There is a high demand for safer alternative therapeutic drugs to combat the risk of infections caused by superbugs (multi-drug resistant bacteria). To find a safer alternative, scientists require rapid analysis and quantification of antimicrobial drug resistance as well as commercial testing of developed drugs. Technology such as cell cytometry helps to collect information about the physical characteristics of cell structure and particles commonly used to evaluate peripheral blood, bone marrow, and other body fluids.
Cell cytometry is a quantitative single-cell technology facilitating research in various fields, including cell biology, immunology, medical microbiology, and oncology. However, traditional cell cytometry has low visualization analysis output, long turnover rates, and is incapable of handling the number of samples—taking longer time for data evaluation. It also lacks data processing software, which becomes the prime reason why pharmaceuticals are able to leverage the technology for drug development. With advances in technology and the involvement of cell cytometry, methods such as flow cytometry and spectral analyzers play a vital role in the fast detection and characterization of cells, thereby accelerating the research to develop novel drugs for the treatment of diseases. Driven by these factors, breakthrough technologies and innovations are driving the future of the cell cytometry market and are expected to grow at a CAGR of 9.9% in the future.
Current Cell Cytometry Market Landscape and Key Drivers
Cell cytometry refers to a smart visualization tool that has been widely adopted for the analysis of physical characterization of the cell cycle, cell proliferation assays, cell sorting, and immunophenotyping. By understanding the cell characteristics, the scientist is able to develop target-specific therapeutic drugs and vaccines that can address the challenges of rising diseases. Though cell cytometry is an essential tool, it comes with certain limitations, such as low throughput and lack of capacity to handle a large number of samples. To overcome the challenge, the cell cytometry market continues to evolve and add technological trends to provide high-tech cytometers with high throughput and large sample handling capacity.
Moreover, the evolution of photonics and optics has a great impact on cell analysis and characterization applications. The novel high throughput flow cytometry has been leveraging photonic developments, including advanced system designs and reliable light sources as well as stable dyes, allowing researchers to have a deeper understanding of cell characteristics.
Recent Innovations in Cell Cytometry Market
Several cell cytometry companies are continually working on advanced variants of cell cytometers to help pharmaceuticals focus on the development of ideal solutions for the treatment of diseases. Some of the recent breakthroughs and innovation that is accelerating the market include:
1. Imaging Flow Cytometry With Digital Computing
The recent advancements in imaging technologies, digital computing, and electronic computing help in the rapid detection of the cell’s characteristics. The IFC (Imaging Flow cytometry) leverages two charge-coupled device cameras with 20x, 40x, and 60x objectives that allow analysis of spatial properties of the cell and morphological study of the cell with better clarity. It also includes dark field and bright field microscopy with up to ten fluorescent channels that combine the single-cell imaging capabilities of the microscopy with higher throughput capabilities. The uses of advanced technology in imaging flow cytometry revolutionize cell analysis, especially of non-adherent cells. It is useful for clinical applications such as detailed analysis of bodily fluids.
2. Time Lapse Cytometers
Time-lapse cytometers offer significant advances in real-time imaging of living cells. The device involves the use of non-heat generating light sources such as light-emitting diodes that allow researchers to place cytometers within a cell-culture incubator for continuous observation of the cell cycle, processes, and sorting without building up heat inside the incubator. Cell cytometry devices offer significant advantages such as quick measurement of numerous characteristics of cells and rapid analysis of large cell libraries at one time—thereby saving plenty of time; researchers invest in cell analysis.
3. Microfluidic Flow Cytometry
Microfluidic flow cytometry is an autonomous alternative to the traditional flow cytometers. It is relatively easy to use and inexpensive than conventional cell cytometry; there is no need to get special training for cell analysis through microfluidic cytometry. The device combines a miniature detection system and microfluidic for PoC (point of caring) diagnosis and high-throughput analysis without altering the performance.
4. Multicolor Flow Cytometry
Multicolor flow cytometry allows for rapid analysis of various cellular populations, such as the detection of immune system cells. The current multicolor flow cytometry enables researchers to explore deep characterization of conjugate antibodies of surface and secreted markers as well as intracellular cells. It is extraordinarily rapid and allows sample analysis of cells ranging up to 10,000 cells per second—an incredible advancement in the visual examination of cells. The multiplexing allows clinicians to collect information with higher throughput.
5. Advances in Hardware
Earlier, the conventional flow cytometers were costly and complex to operate because they were centralized in limited places for cell analysis. However, with the incorporation of advanced technology, the hardware has been changed, and the incorporation of solid-state lasers is offering lots of optical cell analysis in a very small footprint. Moreover, the small silicon-based detector alternatives have been widely accepted in the cell cytometry market and offer detailed cell analysis. The advances in detection technology have helped in the reorganization of nano-particles, such as extracellular vesicles, that can reveal information about disease states.
Overall, the trend and innovation of cell cytometry are entirely focused on high-throughput and rapid analysis. The use of improved integrated flow cytometry systems and sensitive detectors with multi-omics information are taking the central stage, and future advancement in flow cytometry technology will get noticed within the informatics places. Several market players are focusing on leveraging artificial intelligence and machine learning to combine large datasets for cell characteristics study such as surface phenotypes allowing researchers to do detailed descriptions at the cellular level. As the requirement for cell analysis methodologies continues to grow, companies shift to advanced technology for future development of cell cytometry.
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.